Skip to main content
. 2015 Jul 14;26(4):284–292. doi: 10.3802/jgo.2015.26.4.284

Supplementary Table 2. Patients characteristics according to lymphadenectomy.

Parameter No lymphadenectomy (n=89) Pelvic +/-aortic lymphadenectomy (n=165) p-value*
Age (yr) 0.253
 ≤65 51 (57.3) 103 (62.4)
 >65 38 (42.7) 62 (37.6)
Stage <0.001
 IB 28 (31.5) 33 (20.0)
 II 33 (37.1) 40 (24.2)
 IIIA 26 (29.2) 28 (17.0)
 IIIB 2 (2.3) 6 (3.6)
 IIIC 0 (0) 58 (35.2)
Myometrial invasion (%) 0.507
 No 0 0
 ≤50 26 (29.2) 47 (28.5)
 >50 63 (70.8) 118 (71.5)
Grade 0.134
 1 and 2 37 (41.6) 82 (49.7)
 3 52 (58.4) 83 (50.3)
LVSI 0.213
 Negative 62 (69.7) 104 (63.8)
 Positive 27 (30.3) 59 (36.2)
Adjuvant therapy 0.224
 No 20 (22.5) 35 (21.2)
 EBRT 41 (46.1) 57 (34.6)
 Chemo 17 (19.1) 42 (25.5)
 Sequential chemo-EBRT 11 (12.4) 31 (18.8)

Values are presented as number (%).

EBRT, external beam radiotherapy; LVSI, lymphovascular space involvement.

*Fisher exact test or Student t-test.